Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Total Non-Current Liabilities (2020 - 2025)

Historic Total Non-Current Liabilities for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to $379.4 million.

  • Maravai Lifesciences Holdings' Total Non-Current Liabilities fell 3794.37% to $379.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $379.4 million, marking a year-over-year decrease of 3794.37%. This contributed to the annual value of $378.6 million for FY2024, which is 4066.99% down from last year.
  • Maravai Lifesciences Holdings' Total Non-Current Liabilities amounted to $379.4 million in Q3 2025, which was down 3794.37% from $390.8 million recorded in Q2 2025.
  • Maravai Lifesciences Holdings' 5-year Total Non-Current Liabilities high stood at $1.4 billion for Q3 2021, and its period low was $378.6 million during Q4 2024.
  • Moreover, its 5-year median value for Total Non-Current Liabilities was $1.3 billion (2021), whereas its average is $972.6 million.
  • Per our database at Business Quant, Maravai Lifesciences Holdings' Total Non-Current Liabilities soared by 1958.63% in 2021 and then crashed by 5487.28% in 2024.
  • Maravai Lifesciences Holdings' Total Non-Current Liabilities (Quarter) stood at $1.3 billion in 2021, then decreased by 1.78% to $1.3 billion in 2022, then crashed by 51.22% to $638.1 million in 2023, then crashed by 40.67% to $378.6 million in 2024, then grew by 0.21% to $379.4 million in 2025.
  • Its Total Non-Current Liabilities was $379.4 million in Q3 2025, compared to $390.8 million in Q2 2025 and $385.5 million in Q1 2025.